These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20819117)

  • 1. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy.
    Rezkalla SH; Dharmashankar KC; Abdalrahman IB; Kloner RA
    J Interv Cardiol; 2010 Oct; 23(5):429-36. PubMed ID: 20819117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.
    Wang HJ; Lo PH; Lin JJ; Lee H; Hung JS
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):171-6. PubMed ID: 15390241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention.
    Huang RI; Patel P; Walinsky P; Fischman DL; Ogilby JD; Awar M; Frankil C; Savage MP
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):671-6. PubMed ID: 17034064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No-reflow: Still searching for that magic bullet.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):794. PubMed ID: 21104769
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct transfer of ST-elevation myocardial infarction patients for primary percutaneous coronary intervention from short and long transfer distances decreases temporal delays and improves short-term prognosis: the PROGALIAM Registry.
    Estévez-Loureiro R; Calviño-Santos R; Vázquez-Rodríguez JM; Marzoa-Rivas R; Barge-Caballero E; Salgado-Fernández J; Aldama-López G; Barreiro-Díaz M; Varela-Portas J; Freire-Tellado M; Vázquez-González N; Castro-Beiras A
    EuroIntervention; 2010 Aug; 6(3):343-9. PubMed ID: 20884412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning.
    Laskey WK; Yoon S; Calzada N; Ricciardi MJ
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):212-20. PubMed ID: 18546233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes.
    Maluenda G; Ben-Dor I; Delhaye C; Gonzalez MA; Collins SD; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    J Interv Cardiol; 2010 Apr; 23(2):109-13. PubMed ID: 20337859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: a multicenter randomized clinical trial.
    Gao RL; Han YL; Yang XC; Mao JM; Fang WY; Wang L; Shen WF; Li ZQ; Jia GL; Lü SZ; Wei M; Zeng DY; Chen JL; Qin XW; Xu B; DU CH;
    Chin Med J (Engl); 2010 Jun; 123(11):1365-72. PubMed ID: 20819587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction.
    Pasceri V; Pristipino C; Pelliccia F; Granatelli A; Speciale G; Roncella A; Pironi B; Capasso M; Richichi G
    Am J Cardiol; 2005 Jun; 95(11):1358-61. PubMed ID: 15904643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.
    Heestermans AA; van Werkum JW; Zwart B; van der Heyden JA; Kelder JC; Breet NJ; van't Hof AW; Dambrink JH; Koolen JJ; Brueren BR; Zijlstra F; ten Berg JM
    J Thromb Haemost; 2010 Nov; 8(11):2385-93. PubMed ID: 20831622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
    Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E
    Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic intragraft injection of nicardipine prior to saphenous vein graft percutaneous intervention for the prevention of no-reflow: a review and comparison to protection devices.
    Habibzadeh MR; Thai H; Movahed MR
    J Invasive Cardiol; 2011 May; 23(5):202-6. PubMed ID: 21562350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.